36701 |
Oncology |
UBE2C Overexpression Aggravates Patient Outcome by Promoting Estrogen-... |
Front Oncol 2020 10.3389/fonc.2019.01574 |
최윤라 |
2020 |
36700 |
Multidisciplinary Sciences |
Single-cell RNA sequencing demonstrates the molecular and cellular rep... |
NAT COMMUN 2020 10.1038/s41467-020-16164-1 |
최윤라 |
2020 |
36699 |
Oncology |
Outstanding clinical efficacy of PD-1/PD-L1 inhibitors for pulmonary p... |
EUR J CANCER 2020 10.1016/j.ejca.2020.03.029 |
최윤라 |
2020 |
36698 |
Pathology |
Junction Location Identifier (JuLI) Accurate Detection of DNA Fusions ... |
J MOL DIAGN 2020 10.1016/j.jmoldx.2019.10.015 |
최윤라 |
2020 |
36697 |
Biochemistry & Molecular Biology |
Development of Human Monoclonal Antibody for Claudin-3 Overexpressing ... |
BIOMOLECULES 2020 10.3390/biom10010051 |
최윤라 |
2020 |
36696 |
Oncology |
Benefit of Targeted DNA Sequencing in Advanced Non-Small-Cell Lung Can... |
CLIN LUNG CANCER 2020 10.1016/j.cllc.2019.11.006 |
최윤라 |
2020 |
36695 |
Respiratory System |
Impact of diffusing lung capacity before and after neoadjuvant concurr... |
RESP RES 2020 10.1186/s12931-019-1254-0 |
최용수 |
2020 |
36694 |
Respiratory System |
Adjuvant therapy in stage IIIA-N2 non-small cell lung cancer after neo... |
Journal of thoracic disease 2020 10.21037/jtd.2020.03.23 |
최용수 |
2020 |
36693 |
Medicine, General & Internal |
Potential Utility of Therapeutic Drug Monitoring of Adalimumab in Pred... |
J KOREAN MED SCI 2020 10.3346/jkms.2020.35.e114 |
최연호 |
2020 |
36692 |
Medicine, General & Internal |
Successful Sirolimus Treatment for Korean Patients with Activated Phos... |
YONSEI MED J 2020 10.3349/ymj.2020.61.6.542 |
최연호 |
2020 |